Allakos Inc.(ALLK)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ALLK Allakos Inc.

未开盘 04-23 16:00:00 EDT

1.05

-0.01

-0.94%

盘后1.09

+0.04+3.81%

18:48 EDT

最高1.10	最低1.05	成交量26.65万
今开1.05	昨收1.06	日振幅4.72%
总市值9,227万	流通市值6,101万	总股本8,787万
成交额28.38万	换手率0.46%	流通股本5,811万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ALLK","market":"US","secType":"STK","nameCN":"Allakos Inc.","latestPrice":1.05,"timestamp":1713902400000,"preClose":1.06,"halted":0,"volume":266527,"hourTrading":{"tag":"盘后","latestPrice":1.09,"preClose":1.05,"latestTime":"18:48 EDT","volume":4335,"amount":4604.87,"timestamp":1713912484663},"delay":0,"floatShares":58105853,"shares":87873995,"eps":-2.14,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.01,"latestTime":"04-23 16:00:00 EDT","open":1.05,"high":1.1,"low":1.05,"amount":283822.5766948,"amplitude":0.04717,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.14,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1713945600000},"adr":0,"listingDate":1531972800000,"adjPreClose":1.06,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":1.07,"preClose":1.06,"latestTime":"09:12 EDT","volume":6,"amount":6.3800004,"timestamp":1713877929483},"postHourTrading":{"tag":"盘后","latestPrice":1.09,"preClose":1.05,"latestTime":"18:48 EDT","volume":4335,"amount":4604.87,"timestamp":1713912484663},"volumeRatio":0.757461},"requestUrl":"/m/hq/s/ALLK","defaultTab":"news","newsList":[{"id":"2428518405","title":"Allakos Inc.盘中异动 急速拉升5.66%报1.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428518405","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428518405?lang=zh_cn&edition=full","pubTime":"2024-04-18 22:40","pubTimestamp":1713451210,"startTime":"0","endTime":"0","summary":"北京时间2024年04月18日22时40分，Allakos Inc.股票出现异动，股价急速拉升5.66%。截至发稿，该股报1.12美元/股，成交量6.382万股，换手率0.07%，振幅8.02%。Allakos Inc.股票所在的生物技术行业中，整体跌幅为0.21%。Allakos Inc.公司简介：Allakos Inc是一家临床阶段的公司，开发选择性靶向存在于涉及过敏、炎症和增殖性疾病的免疫效应细胞表面的免疫调节受体的治疗性抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041822401187e81c33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041822401187e81c33&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427277488","title":"Allakos Inc.盘中异动 股价大跌5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427277488","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427277488?lang=zh_cn&edition=full","pubTime":"2024-04-16 21:31","pubTimestamp":1713274287,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日21时31分，Allakos Inc.股票出现波动，股价急速下挫5.56%。Allakos Inc.股票所在的生物技术行业中，整体跌幅为0.46%。Allakos Inc.公司简介：Allakos Inc是一家临床阶段的公司，开发治疗性抗体，选择性地针对存在于过敏、炎症和增生性疾病的免疫效应细胞表面的免疫调节受体。在临床前和临床研究中，AK002被证明可以减少嗜酸性粒细胞并抑制肥大细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404162131277a532d1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404162131277a532d1f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427688099","title":"Allakos Inc.盘中异动 大幅下挫5.41%报1.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427688099","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427688099?lang=zh_cn&edition=full","pubTime":"2024-04-16 02:58","pubTimestamp":1713207488,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日02时58分，Allakos Inc.股票出现异动，股价大幅跳水5.41%。截至发稿，该股报1.05美元/股，成交量46.4595万股，换手率0.53%，振幅8.11%。Allakos Inc.股票所在的生物技术行业中，整体跌幅为0.56%。Allakos Inc.公司简介：Allakos Inc是一家临床阶段的公司，开发治疗性抗体，选择性地针对存在于过敏、炎症和增生性疾病的免疫效应细胞表面的免疫调节受体。在临床前和临床研究中，AK002被证明可以减少嗜酸性粒细胞并抑制肥大细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160258087920a6e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160258087920a6e9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426292754","title":"Allakos Inc.盘中异动 股价大涨5.17%报1.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426292754","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426292754?lang=zh_cn&edition=full","pubTime":"2024-04-12 03:58","pubTimestamp":1712865491,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日03时58分，Allakos Inc.股票出现波动，股价急速上涨5.17%。截至发稿，该股报1.22美元/股，成交量29.1428万股，换手率0.33%，振幅6.03%。Allakos Inc.股票所在的生物技术行业中，整体跌幅为0.38%。Allakos Inc.公司简介：Allakos Inc是一家临床阶段的公司，开发治疗性抗体，选择性地针对存在于过敏、炎症和增生性疾病的免疫效应细胞表面的免疫调节受体。在临床前和临床研究中，AK002被证明可以减少嗜酸性粒细胞并抑制肥大细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404120358127a523239&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404120358127a523239&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426111893","title":"Allakos Inc.盘中异动 急速拉升6.19%报1.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426111893","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426111893?lang=zh_cn&edition=full","pubTime":"2024-04-09 22:15","pubTimestamp":1712672151,"startTime":"0","endTime":"0","summary":"北京时间2024年04月09日22时15分，Allakos Inc.股票出现异动，股价快速上涨6.19%。截至发稿，该股报1.20美元/股，成交量8.9381万股，换手率0.10%，振幅4.43%。Allakos Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Allakos Inc.公司简介：Allakos Inc是一家临床阶段的公司，开发治疗性抗体，选择性地针对存在于过敏、炎症和增生性疾病的免疫效应细胞表面的免疫调节受体。在临床前和临床研究中，AK002被证明可以减少嗜酸性粒细胞并抑制肥大细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409221551791f6c36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409221551791f6c36&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425913484","title":"Allakos Inc.盘中异动 大幅跳水5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2425913484","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425913484?lang=zh_cn&edition=full","pubTime":"2024-04-08 22:00","pubTimestamp":1712584808,"startTime":"0","endTime":"0","summary":"北京时间2024年04月08日22时00分，Allakos Inc.股票出现异动，股价快速下挫5.04%。Allakos Inc.股票所在的生物技术行业中，整体涨幅为0.03%。Allakos Inc.公司简介：Allakos Inc是一家临床阶段的公司，开发治疗性抗体，选择性地针对存在于过敏、炎症和增生性疾病的免疫效应细胞表面的免疫调节受体。在临床前和临床研究中，AK002被证明可以减少嗜酸性粒细胞并抑制肥大细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040822000887e7e8f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040822000887e7e8f6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425566904","title":"Allakos Inc.盘中异动 早盘股价大跌5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2425566904","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425566904?lang=zh_cn&edition=full","pubTime":"2024-04-05 21:34","pubTimestamp":1712324047,"startTime":"0","endTime":"0","summary":"北京时间2024年04月05日21时34分，Allakos Inc.股票出现异动，股价快速下挫5.28%。截至发稿，该股报1.17美元/股，成交量2.3642万股，换手率0.03%，振幅3.25%。Allakos Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Allakos Inc.公司简介：Allakos Inc是一家临床阶段的公司，开发治疗性抗体，选择性地针对存在于过敏、炎症和增生性疾病的免疫效应细胞表面的免疫调节受体。在临床前和临床研究中，AK002被证明可以减少嗜酸性粒细胞并抑制肥大细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240405213408791eda11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240405213408791eda11&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425041349","title":"Allakos Inc.盘中异动 股价大跌5.08%报1.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2425041349","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425041349?lang=zh_cn&edition=full","pubTime":"2024-04-05 02:30","pubTimestamp":1712255452,"startTime":"0","endTime":"0","summary":"北京时间2024年04月05日02时30分，Allakos Inc.股票出现异动，股价快速下挫5.08%。截至发稿，该股报1.22美元/股，成交量22.0004万股，换手率0.25%，振幅5.86%。Allakos Inc.股票所在的生物技术行业中，整体跌幅为0.58%。Allakos Inc.公司简介：Allakos Inc是一家临床阶段的公司，开发治疗性抗体，选择性地针对存在于过敏、炎症和增生性疾病的免疫效应细胞表面的免疫调节受体。在临床前和临床研究中，AK002被证明可以减少嗜酸性粒细胞并抑制肥大细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040502305287e7e106&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040502305287e7e106&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421282117","title":"Allakos Inc.盘中异动 临近收盘股价大涨5.04%报1.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421282117","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421282117?lang=zh_cn&edition=full","pubTime":"2024-03-23 03:32","pubTimestamp":1711135939,"startTime":"0","endTime":"0","summary":"北京时间2024年03月23日03时32分，Allakos Inc.股票出现波动，股价急速上涨5.04%。截至发稿，该股报1.36美元/股，成交量39.7854万股，换手率0.45%，振幅5.43%。Allakos Inc.股票所在的生物技术行业中，整体跌幅为0.07%。Allakos Inc.公司简介：Allakos Inc是一家临床阶段的公司，开发治疗性抗体，选择性地针对存在于过敏、炎症和增生性疾病的免疫效应细胞表面的免疫调节受体。在临床前和临床研究中，AK002被证明可以减少嗜酸性粒细胞并抑制肥大细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240323033219861e0802&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240323033219861e0802&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421772096","title":"Allakos Inc.盘中异动 急速上涨5.20%报1.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421772096","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421772096?lang=zh_cn&edition=full","pubTime":"2024-03-21 02:46","pubTimestamp":1710960398,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日02时46分，Allakos Inc.股票出现异动，股价急速拉升5.20%。截至发稿，该股报1.32美元/股，成交量31.5058万股，换手率0.36%，振幅8.17%。Allakos Inc.股票所在的生物技术行业中，整体跌幅为0.26%。Allakos Inc.公司简介：Allakos Inc是一家临床阶段的公司，开发治疗性抗体，选择性地针对存在于过敏、炎症和增生性疾病的免疫效应细胞表面的免疫调节受体。在临床前和临床研究中，AK002被证明可以减少嗜酸性粒细胞并抑制肥大细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321024639861dfd12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321024639861dfd12&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420827047","title":"Allakos Inc.盘中异动 急速上涨5.69%报1.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420827047","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420827047?lang=zh_cn&edition=full","pubTime":"2024-03-20 00:43","pubTimestamp":1710866581,"startTime":"0","endTime":"0","summary":"北京时间2024年03月20日00时43分，Allakos Inc.股票出现波动，股价快速上涨5.69%。截至发稿，该股报1.30美元/股，成交量27.3064万股，换手率0.31%，振幅6.50%。Allakos Inc.股票所在的生物技术行业中，整体跌幅为0.11%。Allakos Inc.公司简介：Allakos Inc是一家临床阶段的公司，开发治疗性抗体，选择性地针对存在于过敏、炎症和增生性疾病的免疫效应细胞表面的免疫调节受体。在临床前和临床研究中，AK002被证明可以减少嗜酸性粒细胞并抑制肥大细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320004302861df75a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320004302861df75a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420547273","title":"Allakos Inc.盘中异动 早盘股价大跌5.34%报1.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420547273","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420547273?lang=zh_cn&edition=full","pubTime":"2024-03-18 21:31","pubTimestamp":1710768672,"startTime":"0","endTime":"0","summary":"北京时间2024年03月18日21时31分，Allakos Inc.股票出现异动，股价快速下跌5.34%。截至发稿，该股报1.24美元/股，成交量8841股，换手率0.01%，振幅0.38%。Allakos Inc.股票所在的生物技术行业中，整体涨幅为0.10%。Allakos Inc.公司简介：Allakos Inc是一家临床阶段的公司，开发治疗性抗体，选择性地针对存在于过敏、炎症和增生性疾病的免疫效应细胞表面的免疫调节受体。在临床前和临床研究中，AK002被证明可以减少嗜酸性粒细胞并抑制肥大细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031821311287e79bfa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031821311287e79bfa&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418553000","title":"Allakos Inc.盘中异动 股价大跌5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2418553000","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418553000?lang=zh_cn&edition=full","pubTime":"2024-03-12 22:05","pubTimestamp":1710252321,"startTime":"0","endTime":"0","summary":"北京时间2024年03月12日22时05分，Allakos Inc.股票出现波动，股价快速下挫5.56%。截至发稿，该股报1.36美元/股，成交量4.5936万股，换手率0.05%，振幅5.90%。Allakos Inc.股票所在的生物技术行业中，整体涨幅为0.41%。Allakos Inc.公司简介：Allakos Inc是一家临床阶段的公司，开发治疗性抗体，选择性地针对存在于过敏、炎症和增生性疾病的免疫效应细胞表面的免疫调节受体。在临床前和临床研究中，AK002被证明可以减少嗜酸性粒细胞并抑制肥大细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403122205227a4bf7a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403122205227a4bf7a9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417256057","title":"Allakos Inc.盘中异动 早盘股价大涨5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417256057","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417256057?lang=zh_cn&edition=full","pubTime":"2024-03-08 22:36","pubTimestamp":1709908575,"startTime":"0","endTime":"0","summary":"北京时间2024年03月08日22时36分，Allakos Inc.股票出现波动，股价快速拉升5.30%。截至发稿，该股报1.39美元/股，成交量1.3767万股，换手率0.02%，振幅2.27%。Allakos Inc.股票所在的生物技术行业中，整体跌幅为0.28%。Allakos Inc.公司简介：Allakos Inc是一家临床阶段的公司，开发治疗性抗体，选择性地针对存在于过敏、炎症和增生性疾病的免疫效应细胞表面的免疫调节受体。在临床前和临床研究中，AK002被证明可以减少嗜酸性粒细胞并抑制肥大细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403082236157918a5f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403082236157918a5f2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417030378","title":"Allakos Inc    预计每股亏损 47 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2417030378","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2417030378?lang=zh_cn&edition=full","pubTime":"2024-03-08 20:03","pubTimestamp":1709899399,"startTime":"0","endTime":"0","summary":"   * Allakos公司   预计在3月11日公布截至2023年12月31日的业绩时，季度收入将不会有任何变化(预计)。*    * LSEG的分析师平均预计Allakos Inc每股亏损47美分。* 目前分析师对该公司股票的平均评级为 \"持有\"，建议的细分为3个 \"强烈买入 \"或 \"买入\"，5个 \"持有\"，1个 \"卖出 \"或 \"强烈卖出\"。* 华尔街对 Allakos Inc 的 12 个月目标价中位数为 2.00 美元，高于其最新收盘价 1.32 美元。3月8日 - 以前季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2417116862","title":"Allakos Inc.盘中异动 临近午盘股价大跌5.00%报1.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417116862","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417116862?lang=zh_cn&edition=full","pubTime":"2024-03-07 00:40","pubTimestamp":1709743255,"startTime":"0","endTime":"0","summary":"北京时间2024年03月07日00时40分，Allakos Inc.股票出现波动，股价快速跳水5.00%。截至发稿，该股报1.33美元/股，成交量21.7144万股，换手率0.25%，振幅7.85%。Allakos Inc.股票所在的生物技术行业中，整体涨幅为0.42%。Allakos Inc.公司简介：Allakos Inc是一家临床阶段的公司，开发治疗性抗体，选择性地针对存在于过敏、炎症和增生性疾病的免疫效应细胞表面的免疫调节受体。在临床前和临床研究中，AK002被证明可以减少嗜酸性粒细胞并抑制肥大细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403070040557a4a23aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403070040557a4a23aa&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416214092","title":"Allakos Inc.盘中异动 大幅下跌5.49%报1.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2416214092","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416214092?lang=zh_cn&edition=full","pubTime":"2024-03-04 23:03","pubTimestamp":1709564621,"startTime":"0","endTime":"0","summary":"北京时间2024年03月04日23时03分，Allakos Inc.股票出现波动，股价急速跳水5.49%。截至发稿，该股报1.55美元/股，成交量7.9544万股，换手率0.09%，振幅5.66%。Allakos Inc.股票所在的生物技术行业中，整体涨幅为0.19%。Allakos Inc.公司简介：Allakos Inc是一家临床阶段的公司，开发治疗性抗体，选择性地针对存在于过敏、炎症和增生性疾病的免疫效应细胞表面的免疫调节受体。在临床前和临床研究中，AK002被证明可以减少嗜酸性粒细胞并抑制肥大细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030423034179171abc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030423034179171abc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416641469","title":"Allakos Inc.盘中异动 早盘股价大涨5.07%报1.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2416641469","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416641469?lang=zh_cn&edition=full","pubTime":"2024-03-01 22:50","pubTimestamp":1709304609,"startTime":"0","endTime":"0","summary":"北京时间2024年03月01日22时50分，Allakos Inc.股票出现异动，股价快速上涨5.07%。截至发稿，该股报1.56美元/股，成交量7.9261万股，换手率0.09%，振幅4.73%。Allakos Inc.股票所在的生物技术行业中，整体涨幅为1.19%。Allakos Inc.公司简介：Allakos Inc是一家临床阶段的公司，开发治疗性抗体，选择性地针对存在于过敏、炎症和增生性疾病的免疫效应细胞表面的免疫调节受体。在临床前和临床研究中，AK002被证明可以减少嗜酸性粒细胞并抑制肥大细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030122500987e75455&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030122500987e75455&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416613524","title":"Allakos Inc    预计每股亏损 47 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2416613524","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2416613524?lang=zh_cn&edition=full","pubTime":"2024-03-01 19:26","pubTimestamp":1709292384,"startTime":"0","endTime":"0","summary":"   * Allakos公司   预计在3月4日公布截至2023年12月31日的业绩时，季度收入将不会有任何变化()    *    * LSEG分析师对Allakos公司的平均预期是每股亏损47美分。* 目前分析师对该公司股票的平均评级为 \"持有\"，建议的细分为3个 \"强烈买入 \"或 \"买入\"，5个 \"持有\"，1个 \"卖出 \"或 \"强烈卖出\"。* 华尔街对 Allakos Inc 的 12 个月目标价中位数为 2.00 美元，高于其最新收盘价 1.48 美元。3月1日 - 以前季度业绩。除非另有说明，所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.allakos.com","stockEarnings":[{"period":"1week","weight":-0.0185},{"period":"1month","weight":-0.2148},{"period":"3month","weight":-0.1017},{"period":"6month","weight":-0.4208},{"period":"1year","weight":-0.7681},{"period":"ytd","weight":-0.6117}],"compareEarnings":[{"period":"1week","weight":-0.0094},{"period":"1month","weight":-0.0412},{"period":"3month","weight":0.0306},{"period":"6month","weight":0.1968},{"period":"1year","weight":0.2123},{"period":"ytd","weight":0.0514}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Allakos Inc.于2012年3月在特拉华州注册成立。该公司是一家临床阶段生物技术公司，开发AK002，它们是完全拥有的单克隆抗体，用于治疗各种嗜酸性粒细胞和肥大细胞相关疾病。 AK002在完成阶段1试验和单次递增剂量阶段1试验（涉及无痛全身性肥大细胞增多症（“ISM”）的患者）中证明了药效学活性，患者报告其症状得到改善。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.248014},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.072416},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.117765},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.024225},{"month":5,"riseRate":0.2,"avgChangeRate":-0.022934},{"month":6,"riseRate":0.6,"avgChangeRate":-0.005738},{"month":7,"riseRate":0.6,"avgChangeRate":0.008991},{"month":8,"riseRate":0.666667,"avgChangeRate":0.307937},{"month":9,"riseRate":0.5,"avgChangeRate":0.032321},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.023477},{"month":11,"riseRate":0.833333,"avgChangeRate":0.180786},{"month":12,"riseRate":0.666667,"avgChangeRate":-0.070932}],"exchange":"NASDAQ","name":"Allakos Inc.","nameEN":"Allakos Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Allakos Inc.(ALLK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Allakos Inc.(ALLK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Allakos Inc.,ALLK,Allakos Inc.股票,Allakos Inc.股票老虎,Allakos Inc.股票老虎国际,Allakos Inc.行情,Allakos Inc.股票行情,Allakos Inc.股价,Allakos Inc.股市,Allakos Inc.股票价格,Allakos Inc.股票交易,Allakos Inc.股票购买,Allakos Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Allakos Inc.(ALLK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Allakos Inc.(ALLK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}